FeesSafety
Pluang+

Empire Market co-creator sentenced to 40 years, ordered to forfeit $100M in Bitcoin.

Market News
11 Oct 2026, 05:09 WIB
Tokenpost
View Source
Bearish
Empire Market co-creator sentenced to 40 years, ordered to forfeit $100M in Bitcoin.

Raheim Hamilton, co-creator of the dark-web marketplace Empire Market, was sentenced to 40 years in prison and fined $5 million by a federal court in Chicago. He must also forfeit about 1,230 Bitcoin worth roughly $100 million, 24.4 Ether, and three properties in Virginia. Empire Market operated from 2018 to 2020, facilitating over four million transactions valued at more than $430 million, mostly from drug sales and other illegal activities. This case highlights ongoing U.S. efforts to crack down on dark-web marketplaces and their cryptocurrency transactions. Hamilton's co-runner, Thomas Pavey, is expected to be sentenced later this month after agreeing to forfeit significant assets.

The Empire Market co-creator's forfeiture of about 1,230 Bitcoin is notable context for readers following cryptocurrency developments. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 11, 2026 08:02 WIB: out of 50 major cryptocurrencies tradable on Pluang, 29 rose and 20 fell today. Among notable movers were SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16,297 with a typical hold time of 85 days, and EOS (EOS.IO) up 8.13% at Rp12,649 with a typical hold time of 87 days.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
1 hour ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
1 hour ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
1 hour ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
1 hour ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App